IRIS
MARRA, ANNAMARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 762
EU - Europa 521
AS - Asia 441
SA - Sud America 9
AF - Africa 2
Totale 1.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 756
CN - Cina 383
IE - Irlanda 190
FI - Finlandia 72
IT - Italia 70
UA - Ucraina 61
DE - Germania 57
SG - Singapore 39
FR - Francia 24
BE - Belgio 19
IN - India 11
GB - Regno Unito 10
BR - Brasile 8
SE - Svezia 8
CA - Canada 5
JP - Giappone 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 2
MU - Mauritius 2
NL - Olanda 2
AM - Armenia 1
BD - Bangladesh 1
DO - Repubblica Dominicana 1
GR - Grecia 1
KR - Corea 1
LT - Lituania 1
PE - Perù 1
TR - Turchia 1
Totale 1.735
Salva come PNG Salva come JPEG
Città #
Dublin 190
Chandler 161
Jacksonville 95
Nanjing 95
Beijing 56
Ann Arbor 53
Ashburn 51
Boardman 46
Nanchang 45
Pavia 39
New York 38
Princeton 33
Singapore 33
Hebei 31
Lawrence 30
Helsinki 29
Changsha 28
Wilmington 25
Jiaxing 22
Tianjin 22
Shanghai 20
Shenyang 20
Piscataway 19
Medford 17
Brussels 15
Hangzhou 13
Seattle 11
Milan 9
Pune 8
Los Angeles 7
Munich 7
Couilly-pont-aux-dames 6
Woodbridge 6
Fairfield 5
Guangzhou 5
Toronto 5
Aachen 4
Tokyo 4
Dallas 3
Dearborn 3
Tappahannock 3
Brno 2
Chicago 2
Fuzhou 2
Jinan 2
Moscow 2
Newark 2
Norwalk 2
Stockholm 2
Turin 2
Americana 1
Amsterdam 1
Borås 1
Campo Grande 1
Chengdu 1
Des Moines 1
Dhaka 1
Donetsk 1
Escada 1
Gallarate 1
Itajaí 1
Jinhua 1
Lima 1
Ningbo 1
Novokuznetsk 1
Orange 1
Padova 1
Prineville 1
Qingdao 1
Ribeirão Preto 1
Rio de Janeiro 1
Rozzano 1
Shaoxing 1
Shenzhen 1
Shijiazhuang 1
Sorocaba 1
São Paulo 1
Tekirdağ 1
Temecula 1
West Palm Beach 1
Yerevan 1
Zhengzhou 1
Totale 1.362
Salva come PNG Salva come JPEG
Nome #
A step forward in understanding the binding of ELAV mimicking peptides to mRNA. An integrated computational and NMR approach 98
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 92
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 87
Sigma receptor modulators: a patent review. 80
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 79
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 77
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 76
A step forward in the sigma enigma: the role of chirality in the interaction ligand-sigma1 receptor 71
Beyond the affinity for protein kinase C: Exploring 2-phenyl-3-hydroxypropyl pivalate analogues as C1 domain-targeting ligands 70
New biotinilated spacers for studying the interaction of ELAV mimicking peptides with the target mRNA 67
Towards sigma1 receptor agonists as neuroprotective agents. Preparation, configurational assignment and in vitro biological profile 66
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 60
PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106 59
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 58
Beyond the affinity for the Protein Kinase C: a critical evaluation of 2-fenil-3hydroxypropyl pivalate analogs targeting the C1 domain 56
Use of arylalkanolamines as sigma-1 receptor antagonists 55
Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical Spectroscopy 54
“Fit-for-purpose” development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel sigma1 receptor agonist. 52
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 51
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents 51
Sigma Receptors: Novel Targets For The Treatment Of Highly Malignant Tumors 51
In vivo pharmacokinetic study and CNS distribution of the sigma1 receptor agonist (R)-RC-33, a promising neuroprotective agent 51
Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent. 49
On the study of stereoselectivity in the ligand - Sigma1 receptor interaction. 48
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 48
Novel enantiopure sigma receptor modulators: Quick (semi-)preparative chiral resolution via hplc and absolute configuration assignment 48
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 41
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 38
Towards the identification of neuroprotective agents. Pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising sigma1 receptor agonist 32
Towards sigma1 receptor agonists as neuroprotective agents. Chemical and pharmacological studies of RC-33 enantiomers 25
Sigma receptor and aquaporin modulators: chiral resolution, configurational assignment, and preliminary biological profile of RC752 enantiomers 14
Totale 1.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 0 0 1 19 20 25 30 2
2020/2021149 13 14 2 16 2 22 0 30 12 22 13 3
2021/2022160 1 2 4 2 3 3 2 9 14 3 17 100
2022/2023498 56 48 4 29 41 48 0 27 218 5 10 12
2023/2024234 30 27 1 4 19 75 13 16 2 8 27 12
2024/2025151 9 38 20 10 33 22 19 0 0 0 0 0
Totale 1.804